Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online
December 3, 2024 | HTA, Health Technology Assessments, ISPOR Europe, Payers, RWE, ispor, payer insights, real-world evidence
Genesis Research Group’s poster ‘Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey’ was recently named as ‘Best General Poster Research Presentation’ for ISPOR Europe 2024.
Along with other Genesis Research Group presentations, the poster has recently been featured by The Evidence Base in an interview entitled ‘Payer Perspectives on Key Challenges in Healthcare Decision-Making: actionable insights for life sciences companies’.
Prior to being awarded ‘Best General Poster Research Presentation‘ for ISPOR Europe 2024, authors of the poster ‘Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey‘ were interviewed by The Evidence Base alongside other Genesis Research Group authors.
Payer perspectives are essential in ensuring that new treatments demonstrate not only clinical efficacy but also cost-effectiveness, while aligning with the priorities and sustainability of healthcare systems. For life sciences companies, understanding payer approaches to the complex challenges of reimbursement decision-making—including budget impact assessments, cost-effectiveness analyses, and evaluations of clinical value—is critical for shaping patient access to innovative therapies and informing healthcare policy.
In this interview, The Evidence Base spoke with Tijana Ignjatovic, Darrin Benjumea, and Manica Agrawal about new research that focuses on gathering payer perspectives on these key issues in healthcare. The survey results were recently presented at ISPOR Europe 2024 (November 17–20, 2024, Barcelona, Spain).
Darren Benjumea was the co-author and presenter of the previously mentioned ISPOR Europe winning poster, the additional authors being Tijana Ignjatovic, Alice Jackson, Kristen Downs, and Lynn Okamoto.
Congratulations to the Genesis Research Group team!
You can read the article online or contact Genesis Research Group at solutions@genesisrg.com if you’d like a copy of the poster.
This content was provided by Genesis Research Group
Company Details
Latest Content from Genesis Research Group
Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.
In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group’s recent expansion of its real-world data…
Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program
Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural…
Genesis Research Group survey discovers how payers are responding to Maximum Fair Prices (MFPs) under the Inflation Reduction Act
To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform and vetted stakeholder network to…
Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication
We are pleased to share that The Evidence Base have carried out a ‘deep dive’ into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights…
Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online
Genesis Research Group’s poster ‘Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey’ was recently named as…
Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group
A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition…
Genesis Research Group unveils enhanced US market access data analytics
Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities…
Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers
Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.
Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program
Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life…
Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on ‘Advancing Healthcare’
ITN Business invited Genesis Research Group to contribute to a news style programme ‘Advancing Healthcare’ featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one…